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PCoronary Artery Disease
oninvasive Identification of Patients
ith Early Coronary Atherosclerosis by
ssessment of Digital Reactive Hyperemia
iero O. Bonetti, MD,* Geralyn M. Pumper, RN,* Stuart T. Higano, MD, FACC,*
avid R. Holmes, JR, MD, FACC,* Jeffrey T. Kuvin, MD, FACC,† Amir Lerman, MD, FACC*
ochester, Minnesota; and Boston, Massachusetts
OBJECTIVES We investigated the value of reactive hyperemia peripheral arterial tonometry (RH-PAT) as
a noninvasive tool to identify individuals with coronary microvascular endothelial dysfunction.
BACKGROUND Coronary endothelial dysfunction, a systemic disorder, represents an early stage of athero-
sclerosis; RH-PAT is a technique to assess peripheral microvascular endothelial function.
METHODS Using RH-PAT, digital pulse volume changes during reactive hyperemia were assessed in 94
patients without obstructive coronary artery disease and either normal (n  39) or abnormal
(n  55) coronary microvascular endothelial function; RH-PAT index, a measure of reactive
hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia
divided by that at baseline.
RESULTS Average RH-PAT index was lower in patients with coronary endothelial dysfunction
compared with those with normal coronary endothelial function (1.27 0.05 vs. 1.78 0.08:
p 0.001). An RH-PAT index1.35 was found to have a sensitivity of 80% and a specificity
of 85% to identify patients with coronary endothelial dysfunction.
CONCLUSIONS Digital hyperemic response, as measured by RH-PAT, is attenuated in patients with coronary
microvascular endothelial dysfunction, suggesting a role for RH-PAT as a noninvasive test to
identify patients with this disorder. (J Am Coll Cardiol 2004;44:2137–41) © 2004 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.062American College of Cardiology Foundation
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indothelial dysfunction represents an early stage of coro-
ary artery disease (CAD) (1). The presence of endothelial
ysfunction in coronary or peripheral vessels constitutes an
ndependent predictor of cardiovascular events (2). Given
hat endothelial dysfunction is reversible, early detection of
his disorder may have therapeutic and prognostic implica-
ions (2).
Assessment of coronary endothelial function may be
onsidered the “gold standard” of endothelial function
esting (3). However, because endothelial dysfunction is not
onfined to the coronary arteries, less invasive techniques for
he assessment of peripheral vascular endothelial function
ave been developed (4,5). Although these methods are
idely used research tools, their operator dependency or
omplexity preclude their use in clinical practice (2,5). Thus,
n order to promote endothelial function testing as a
creening method for individuals at increased cardiovascular
isk, techniques to easily assess endothelial function are
eeded.
Reactive hyperemia peripheral arterial tonometry (RH-PAT)
s a noninvasive technique to assess peripheral microvascular
From the *Center for Coronary Physiology and Imaging, Division of Cardiovas-
ular Diseases, Mayo Clinic, Rochester, Minnesota; and the †Division of Cardiology,
ew England Medical Center Hospitals, Tufts University School of Medicine,
oston, Massachusetts. Supported by the National Institutes of Health (HL-63911
nd HL-69840), the Mayo Foundation, and an unrestricted grant from Itamar
edical Ltd.v
Manuscript received April 22, 2004; revised manuscript received August 16, 2004,
ccepted August 23, 2004.ndothelial function by measuring changes in digital pulse
olume during reactive hyperemia (6,7). This study was de-
igned to investigate the relationship between coronary and
eripheral microvascular endothelial function and to assess the
alue of RH-PAT as a tool to identify individuals with
oronary endothelial dysfunction.
ETHODS
atients. This study was approved by the Mayo Clinic
nstitutional Review Board. Ninety-four consecutive pa-
ients, who were referred for coronary angiography to
xclude CAD and were found to have no significant
picardial coronary stenoses (30% diameter), were studied
rospectively. Exclusion criteria included prior myocardial
nfarction; percutaneous coronary intervention; coronary
rtery bypass graft surgery; unstable or variant angina; an
jection fraction 50%; valvular heart disease; peripheral
ascular disease; uncontrolled arterial hypertension; allergy
o latex; and/or significant endocrine, hepatic, renal, or
nflammatory disease. Cardiovascular medications were
ithheld for at least 48 h before cardiac catheterization.
oronary and RH-PAT studies were performed in the
asting state.
ssessment of coronary vasoreactivity. After diagnostic
oronary angiography and exclusion of significant CAD,
easurements of endothelium-dependent and endothelium-
ndependent coronary flow reserve were performed as pre-
iously described (3,8,9). According to previous studies,
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Reactive Hyperemia and Endothelial Function December 7, 2004:2137–41ormal coronary endothelial function was defined as an
ncrease in coronary blood flow (CBF) of50% in response
o the maximum dose of acetylcholine (8,9).
H-PAT. The principle of peripheral arterial tonometry
PAT) has been recently described (6,7). Briefly, this system
Itamar Medical Ltd., Caesarea, Israel) comprises a finger
robe to assess digital volume changes accompanying pulse
aves.
The RH-PAT measurements and cardiac catheterization
ere performed on the same day; RH-PAT studies were
arried out at least 3 h after cardiac catheterization in a
hermoneutral environment. According to previous studies
6), a blood pressure cuff was placed on one upper arm
study arm), while the other arm served as a control (control
rm). Peripheral arterial tonometry probes were placed on
ne finger of each hand for continuous recording of the
AT signal. After a 10-min equilibration period, the blood
Abbreviations and Acronyms
CAD  coronary artery disease
CBF  coronary blood flow
L-NAME N-nitro-L-arginine methyl ester
NO  nitric oxide
PAT  peripheral arterial tonometry
RH-PAT  reactive hyperemia peripheral arterial
tonometry
ROC  receiver operating characteristicigure 1. Representative reactive hyperemia peripheral arterial tonometry recor
ormal response is characterized by a distinct increase in the signal amplituderessure cuff was inflated to suprasystolic pressures for 5
in. Then the cuff was deflated, while PAT recording
ontinued for 10 min (Fig. 1). A total of 19 patients with
ormal coronary endothelial function and 17 patients with
oronary endothelial dysfunction agreed to take 0.4-mg
itroglycerin sublingually to assess endothelium-independent
AT response. In these patients nitroglycerin was given 10
in after cuff deflation, and 10 min later PAT recording
as stopped.
The RH-PAT data were analyzed by a computer in an
perator-independent manner as previously described (6).
s a measure of reactive hyperemia, RH-PAT index was
alculated as the ratio of the average amplitude of the PAT
ignal over a 1-min time interval starting 1 min after cuff
eflation divided by the average amplitude of the PAT
ignal of a 3.5-min time period before cuff inflation (base-
ine). Subsequently, RH-PAT index values from the study
rm were normalized to the control arm. The choice to use
he average 1-min PAT signal starting 1 min after cuff
eflation to describe the magnitude of reactive hyperemia
as based on the observation that this time interval pro-
ided the best information regarding detection of coronary
ndothelial dysfunction as determined by receiver operating
haracteristic (ROC) curve analysis as well as the best
orrelation with CBF response to acetylcholine. Hyperemic
esponse to nitroglycerin was similarly assessed; average
AT signal amplitude of four consecutive 1-min periods
tarting at 5 min after administration of sublingual nitro-dings of subjects with normal and abnormal reactive hyperemic response.
after cuff release compared with baseline.
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ponse to nitroglycerin was then calculated as the ratio of
he PAT amplitude of the 1-min interval during which peak
verage PAT signal was recorded divided by the amplitude
f the baseline PAT signal (nitroglycerin-PAT index).
Determination of reproducibility of RH-PAT measure-
ents was described earlier (6).
tatistical analysis. Results are expressed as mean values
EM. Fisher exact test and unpaired t test or analysis of
ariance was used to compare differences between groups.
he ROC curve analysis was done to identify the RH-PAT
ndex value for optimal discrimination between presence/
bsence of coronary endothelial dysfunction. Simple linear
egression and multivariable analysis using a backward
tepwise regression model were utilized for evaluation of
ossible associations between RH-PAT index and various
linical variables and cardiovascular risk factors. Multivari-
ble analysis included all variables that were tested in
nivariable analysis. The ROC curve analysis was done by
PSS statistical software (SPSS Inc., Chicago, Illinois). All
ther analyses were done by StatView statistical data anal-
sis software (SAS Institute, Cary, North Carolina). Statis-
ical significance was accepted for p  0.05.
ESULTS
total of 94 patients were studied; 39 had normal coronary
ndothelial function, and 55 had coronary endothelial dys-
unction (Table 1).
Average RH-PAT index was higher in individuals with
ormal coronary endothelial function than in those with
oronary endothelial dysfunction (1.78  0.08 vs. 1.27 
.05; p  0.001).
Linear regression analysis identified a significant relation-
hip between RH-PAT index and CBF response to acetyl-
holine (r  0.405, p  0.001). In addition, univariable
nalysis revealed significant relationships between RH-PAT
ndex and body mass index as well as high-density lipopro-
ein cholesterol levels (Table 2). However, multivariable
nalysis identified CBF response to acetylcholine as the only
ndependent predictor of RH-PAT index (p  0.006).
By ROC curve analysis, an RH-PAT index of 1.35 was
dentified as the best discriminating value between individ-
als with normal and abnormal coronary endothelial func-
ion (Fig. 2). For an RH-PAT index value 1.35, the
ensitivity and specificity for the detection of coronary
ndothelial dysfunction were 80% and 85%, respectively.
hen the patients were divided based on this cutoff value,
significant difference in the average CBF response to
cetylcholine was found between patients with an RH-PAT
ndex of 1.35 and those with a value of 1.35 (70.0 
1.9% vs. 6.5  8.7%; p  0.001). In contrast, there was no
ifference in the endothelium-independent coronary flow
eserve to adenosine between these two groups (3.0  0.1
s. 3.1  0.1; p  0.711); PAT response to nitroglycerin
as similar in patients with normal and abnormal coronary cndothelial function (nitroglycerin-PAT index 1.42  0.13
nd 1.33  0.13; p  0.628).
ISCUSSION
his study demonstrates that patients with coronary micro-
ascular endothelial dysfunction have a lower peripheral
yperemic response, as measured by RH-PAT, than those
ith normal coronary endothelial function, suggesting a
otential role for RH-PAT as a noninvasive test to identify
ndividuals with coronary endothelial dysfunction.
Reactive hyperemia peripheral arterial tonometry repre-
ents a noninvasive technique for measuring digital reactive
yperemia, which is partly mediated by endothelium-
erived nitric oxide (NO) (10). Thus, the magnitude of
eactive hyperemia may serve as an index of peripheral
icrovascular endothelial function. Indeed, an excellent
able 1. Clinical Characteristics of Patients With Normal and
bnormal Coronary Endothelial Function
Normal
Coronary
Endothelial
Function
(n  39)
Abnormal
Coronary
Endothelial
Function
(n  55)
ge (yrs) 50 2 49  2
ale, n (%) 16 (41) 23 (42)
MI (kg/m2) 28.2  0.8 29.5  0.9
ypercholesterolemia, n (%) 19 (49) 31 (56)
ypertension, n (%) 21 (54) 20 (36)
iabetes, n (%) 2 (5) 6 (11)
moking, n (%) 15 (38) 23 (42)
amily history of CAD, n (%) 30 (77) 41 (75)
CE inhibitor, n (%) 7 (18) 10 (18)
eta-blocker, n (%) 13 (33) 17 (31)
alcium channel blocker, n (%) 19 (49) 23 (42)
itrate, n (%) 19 (49) 29 (53)
ipid-lowering medication, n (%) 11 (28) 22 (40)
otal cholesterol (mmol/l) 4.8 0.2 4.7  0.2
DL cholesterol (mmol/l) 2.8  0.1 2.8  0.1
DL cholesterol (mmol/l) 1.4 0.1 1.3  0.1
riglycerides (mmol/l) 1.4  0.2 1.5  0.2
asting blood glucose (mmol/l) 5.5 0.2 5.7  0.2
eart rate (beats/min) 69  2 67  1
ystolic blood pressure (mm Hg) 128 3 126  2
iastolic blood pressure (mm Hg) 75  2 73  1
ulse pressure (mm Hg) 53  3 53  2
VEF (%) 64 1 63  1
CBF (Ach), % 107.3  8.8 12.9  6.2*
CAD (Ach), % 0.7  1.9 27.6  4.3*
FR 2.9 0.1 3.1  0.1
CBF (NTG), % 22.7 10.4 15.4  8.9
CAD (NTG), % 13.3 2.7 14.8  2.4
alues are mean  SEM or n (%). *p  0.001 vs. normal coronary endothelial
unction group.
ACE  angiotensin-converting enzyme; BMI  body mass index; CFR 
ndothelium-independent coronary flow reserve to adenosine; HDL  high-density
ipoprotein; LDL  low-density lipoprotein; LVEF  left ventricular ejection
raction; CAD (Ach)  change in coronary artery diameter in response to
cetylcholine; CAD (NTG)  change in coronary artery diameter in response to
itroglycerin; CBF (Ach)  change in coronary blood flow in response to
cetylcholine; CBF (NTG)  change in coronary blood flow in response to
itroglycerin.orrelation between forearm blood flow response to reactive
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as demonstrated (11).
Reactive hyperemia peripheral arterial tonometry mea-
ures digital pulse volume at rest and during reactive
yperemia. Although digital pulse volume is modulated by
arious local, systemic, and environmental factors, this
arameter is also affected by the bioavailability of NO and,
herefore, also depends on endothelial function (12). The
ole of endothelium-derived NO in the RH-PAT response
as investigated in a preliminary study, in which RH-PAT
esting was performed before and during brachial artery
nfusion of N-nitro-L-arginine methyl ester (L-NAME),
n inhibitor of NO synthesis, in healthy volunteers (7). In
his study, L-NAME reduced RH-PAT index significantly
able 2. Univariate Analysis of Potential Clinical Predictors of
he RH-PAT Index
Variables r p Value
CBF (Ach) 0.405 0.001
ge 0.129 0.215
MI 0.238 0.021
eight 0.091 0.379
eight 0.126 0.224
eart rate 0.128 0.217
ystolic blood pressure 0.105 0.312
iastolic blood pressure 0.179 0.083
ulse pressure 0.048 0.645
otal cholesterol 0.212 0.840
DL cholesterol 0.007 0.951
DL cholesterol 0.255 0.014
riglycerides 0.055 0.600
amily history of CAD 0.040 0.703
iabetes 0.032 0.761
moking 0.040 0.701
H-PAT  reactive hyperemia peripheral arterial tonometry; other abbreviations as
n Table 1.
igure 2. Receiver operating characteristic curve for the reactive hyperemia
eripheral arterial tonometry (RH-PAT) index to identify patients with
ormal coronary endothelial function. An RH-PAT index of 1.35 discrim-h
nates best between presence/absence of coronary endothelial dysfunction.
UC  area under the curve.y 61%. Taken together, measuring reactive hyperemia by
H-PAT provides a noninvasive means for assessing pe-
ipheral microvascular endothelial function.
Average RH-PAT index was significantly lower in indi-
iduals with coronary endothelial dysfunction. Moreover,
nd similar to a study by Anderson et al. (13), we found a
ignificant correlation between RH-PAT index and the
BF response to acetylcholine. This moderate correlation
ay be secondary to the differential response of vascular
eds to different stimuli. Therefore, defining a cutoff value
ay represent a more accurate method to compare endo-
helial function between peripheral and coronary vessels.
ndeed, using ROC curve analysis, we found a sensitivity of
0% and a specificity of 85% for an RH-PAT index 1.35
o identify patients with coronary endothelial dysfunction.
The similar PAT response to nitroglycerin in individuals
ith normal and abnormal coronary endothelial function
upports the concept that the RH-PAT index represents a
easure of endothelial function. This is underscored by the
imilar endothelium-independent coronary flow reserve in
oth groups when patients were divided based on an
H-PAT index of 1.35.
To minimize the impact of confounding factors on the
H-PAT results, a two-pronged approach was used. First,
he reactive hyperemic response was referenced to a baseline
erived from the same finger in order to eliminate local
nger-related effects. Second, the effect of systemic factors
as minimized by normalizing the RH-PAT value of the
tudy arm to the corresponding PAT signal of the control
rm. Other factors affecting peripheral vascular tone, like
emperature, were less of a concern in our study because
nvironmental conditions during testing were kept equal for
ll patients.
The present study has several limitations. Only patients
ith chest pain undergoing cardiac catheterization were
ncluded. Similar to a previous study (8), distribution of
raditional risk factors was similar among patients with
ormal and abnormal coronary endothelial function. This
ay explain the absence of a significant relationship be-
ween traditional risk factors and RH-PAT index and may
lso suggests the possibility of a selection bias that may limit
ranslation of the results to a general population. Another
otential limitation pertains to the definition of coronary
ndothelial dysfunction used. The role of coronary endo-
helial dysfunction as an independent risk factor for cardio-
ascular events is well established (2). Thus, our definition
f coronary endothelial dysfunction was based on previous
tudies demonstrating the adverse prognostic impact of an
ncrease in CBF to acetylcholine of50% (8,9). Finally, our
esults cannot be transferred to patients with heart failure or
utonomous nervous system dysfunction who may show
lterations of the peripheral circulation. Given these limi-
ations, our results require independent confirmation and
urther validation in different populations.
In summary, our study demonstrates that digital reactive
yperemia, as measured by RH-PAT, is attenuated in
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ith individuals with normal coronary endothelial function.
his suggests a role for RH-PAT as a noninvasive tool to
dentify patients during the early stage of CAD.
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